Pirarubicin‐induced Endothelium‐dependent Relaxation in Rat Isolated Aorta

S. Hirano,N. Agata,Y. Hara,H. Iguchi,M. Shirai,H. Tone,N. Urakawa

DOI: https://doi.org/10.1111/j.2042-7158.1991.tb03193.x

1991-12-01

Abstract:Abstract— The mechanism of relaxation produced by pirarubicin [(2″R)‐4′‐O‐tetrahydropyranyladriamycin, THP] has been studied in rat isolated aorta. THP (1·5 × 10−6–4·5 × 10−5 m) markedly relaxed contractions induced by noradrenaline (10−7 m) in the aorta with endothelium, but not in that without endothelium. The relaxation induced by 1·5 × 10−5 m THP was inhibited by methylene blue (5 × 10−6 m), hydroquinone (10−4 m), phenidone (5 × 10−5 m), haemoglobin (10−6 m) and p‐bromophenacyl bromide (5×10−5 m), but not by indomethacin (2·5 ×10−5 m). The relaxation induced by THP (1·5 × 10−7 − 4·5 × 10−5 m) was inhibited by NG‐nitro‐l‐arginine (10−5 m), but enhanced by superoxide dismutase (10 units mL−1) or by L‐arginine (10−2 m). However, the THP‐induced relaxation was not inhibited by various receptor antagonists such as atropine (10−6 m), cimetidine (10−5 m), diphenhydramine (3 × 10−6 m) and [D‐Pro4, D‐Trp7,9,10]‐substance P(4–11) (1·5 × 10−6 m). In fifteen anthracycline analogues, THP and 13‐dihydropirarubicin (both with a tetrahydropyranyl group) produced endothelium‐dependent relaxations. These results suggest that the THP‐induced relaxation which is probably mediated by endothelium‐derived relaxing factor (EDRF) was not produced by an activation of muscarine, histamine H1 or H2, or substance P receptor, and further that the tetrahydropyranyl group must play an important role in the THP‐induced relaxation.